Evaluation of PillCam® Express Capsule Endoscopy Delivery System (RD-300)
|Small Bowel Disease Inflammatory Bowel Disease||Device: PillCam® Express Capsule Endoscopy Delivery System|
|Study Design:||Intervention Model: Single Group Assignment
Masking: Single (Investigator)
Primary Purpose: Diagnostic
|Official Title:||Evaluation of PillCam® Express Capsule Endoscopy Delivery System|
- Number of Participants With Successful Capsule Placment Into the Duodenum Using Capsule Delivery System [ Time Frame: up to 7 days ]The number of capsules that successfully were in the duodenum as indicated by video images
- Percentage of Capsule Placement Success Using PillCam® Express Capsule Endoscopy Delivery System [ Time Frame: up to 7 days ]
|Study Start Date:||October 2009|
|Study Completion Date:||May 2010|
|Primary Completion Date:||May 2010 (Final data collection date for primary outcome measure)|
Device: PillCam® Express Capsule Endoscopy Delivery System
The PillCam® Express Capsule Endoscopy Delivery System is comprised of three parts: a catheter, a syringe and the capsule holder. The catheter is passed through the accessory channel of a standard endoscope and the capsule holder is snapped on to the distal end of the device. The endoscope is used to guide the Capsule Endoscopy Delivery System to the proximal duodenum. The capsule is then released pneumatically, using an air-filled syringe attached to the proximal end of the catheter.
Once the capsule is deployed, the endoscope is withdrawn and the capsule holder is cut off at the distal part of the device with scissors. The catheter is then retracted and discarded.
The PillCam® Express Capsule Endoscopy Delivery System is single-use, disposable and latex-free.
Natural ingestion of a wireless capsule endoscope (e.g. PillCam™ SB) is contraindicated in subjects with oropharyngeal or mechanical dysphagia, gastroparesis and known or suspected anatomical abnormalities. In addition, ingestion of a wireless capsule endoscope may be challenging in the pediatric population. The PillCam® Express Capsule Endoscopy Delivery System is intended to provide physicians with the capability to place capsules in the proximal duodenum using the accessory channel of a standard endoscope.
The PillCam™ SB capsule to be used in this study was cleared by the FDA in August 2001 for small bowel evaluation. It has been ingested to date by more than 1,000,000 people worldwide and is well accepted by subjects and physicians as well as the professional societies.
Further details of the PillCam®Express Capsule Endoscopy Delivery System can be found in the device description section.
This study is designed to evaluate the performance and safety of the Capsule Endoscopy Delivery System in subjects indicated to undergo a standard Esophagogastroduodenoscopy (EGD) endoscopy
Please refer to this study by its ClinicalTrials.gov identifier: NCT01088646
|United States, Alabama|
|Alabama Digestive Disorders Center, P. C.|
|Huntsville, Alabama, United States, 35802|
|Alabama Liver and Digestive Specialists|
|Montgomery, Alabama, United States, 36116|
|United States, New York|
|RANY -Research Associates of New York (NY Gastroenterology Associates)|
|New York, New York, United States, 10021|
|Principal Investigator:||Jonathan Leighton, MD||Mayo Clinic|
|Principal Investigator:||Peter Legnani, MD||Private Practice New York, New York|